UPMC Cancer Center/Hillman Cancer Center ( Site 5017)

Pittsburgh, Pennsylvania 15232

1 studies enrolling now · 1 studies all time

What they study most

Renal Cell Carcinoma

Studies at this site

• Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03) — Recruiting now